Roivant Sciences Ltd.

ROIVNasdaq· Pharmaceutical Preparations

Price History

Revenue

$29.1M

▼ 11.2% YoY

Net Income

-$172.0M

▼ 104.0% YoY

EPS

$-0.24

▼ 104.6% YoY

Cash

$2.7B

▼ 58.2% YoY

FY 2025 · As of 2025-03-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.